Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 869557Generated: October 27, 2026

4-chloro-2-cyclopropyl-1H-benzo[d]imidazole → (E)-2-{8-[(4-chloro-2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}-2-cyclopropylacetonitrile

https://huagongshe.com/reaction/869557

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-chloro-2-cyclopropyl-1H-benzo[d]imidazoleHCID 60978792—
Reactant(E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrileHCID 86721388—
Product(E)-2-{8-[(4-chloro-2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}-2-cyclopropylacetonitrileHCID 8672139074.8%

Reaction Steps

Using 4-chloro-2-cyclopropyl-1H-benzo[d]imidazole (EP1988091, 60 mg, 0.31 mmol) and (E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrile (120 mg, 0.31 mmol) obtained in Reference Example 6, and in the same manner as in Reference Example 1A, the title compound (115 mg, 74%) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08969345B2
Source datasetuspto-grants-2015_03
ORD IDord-23f2afecee18464488149da6a72e37d7
Source noteuspto-grants-2015_03